Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Aged and Diseased Neurons Get Lost in Transport.

Tamburrino A, Decressac M.

Trends Neurosci. 2016 Apr;39(4):199-201. doi: 10.1016/j.tins.2016.02.007. Epub 2016 Mar 9.

PMID:
26970902
2.

Targeting α-synuclein: Therapeutic options.

Dehay B, Decressac M, Bourdenx M, Guadagnino I, Fernagut PO, Tamburrino A, Bassil F, Meissner WG, Bezard E.

Mov Disord. 2016 Jun;31(6):882-8. doi: 10.1002/mds.26568. Epub 2016 Mar 1. Review.

PMID:
26926119
3.

Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's disease.

Tamburrino A, Churchill MJ, Wan OW, Colino-Sanguino Y, Ippolito R, Bergstrand S, Wolf DA, Herz NJ, Sconce MD, Björklund A, Meshul CK, Decressac M.

Acta Neuropathol Commun. 2015 Dec 14;3:84. doi: 10.1186/s40478-015-0263-6.

4.

Nurr1 and Retinoid X Receptor Ligands Stimulate Ret Signaling in Dopamine Neurons and Can Alleviate α-Synuclein Disrupted Gene Expression.

Volakakis N, Tiklova K, Decressac M, Papathanou M, Mattsson B, Gillberg L, Nobre A, Björklund A, Perlmann T.

J Neurosci. 2015 Oct 21;35(42):14370-85. doi: 10.1523/JNEUROSCI.1155-15.2015.

5.

Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit.

Tozzi A, de Iure A, Bagetta V, Tantucci M, Durante V, Quiroga-Varela A, Costa C, Di Filippo M, Ghiglieri V, Latagliata EC, Wegrzynowicz M, Decressac M, Giampà C, Dalley JW, Xia J, Gardoni F, Mellone M, El-Agnaf OM, Ardah MT, Puglisi-Allegra S, Björklund A, Spillantini MG, Picconi B, Calabresi P.

Biol Psychiatry. 2016 Mar 1;79(5):402-414. doi: 10.1016/j.biopsych.2015.08.013. Epub 2015 Aug 20.

PMID:
26392130
6.

NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.

Decressac M, Volakakis N, Björklund A, Perlmann T.

Nat Rev Neurol. 2013 Nov;9(11):629-36. doi: 10.1038/nrneurol.2013.209. Epub 2013 Oct 15. Review.

PMID:
24126627
7.

mTOR inhibition alleviates L-DOPA-induced dyskinesia in parkinsonian rats.

Decressac M, Björklund A.

J Parkinsons Dis. 2013;3(1):13-7. doi: 10.3233/JPD-120155.

PMID:
23938307
8.

TFEB: Pathogenic role and therapeutic target in Parkinson disease.

Decressac M, Björklund A.

Autophagy. 2013 Aug;9(8):1244-6. doi: 10.4161/auto.25044. Epub 2013 May 22.

9.

TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.

Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Björklund A.

Proc Natl Acad Sci U S A. 2013 May 7;110(19):E1817-26. doi: 10.1073/pnas.1305623110. Epub 2013 Apr 22.

10.

Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons.

Kadkhodaei B, Alvarsson A, Schintu N, Ramsköld D, Volakakis N, Joodmardi E, Yoshitake T, Kehr J, Decressac M, Björklund A, Sandberg R, Svenningsson P, Perlmann T.

Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2360-5. doi: 10.1073/pnas.1221077110. Epub 2013 Jan 22.

11.

α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons.

Decressac M, Kadkhodaei B, Mattsson B, Laguna A, Perlmann T, Björklund A.

Sci Transl Med. 2012 Dec 5;4(163):163ra156. doi: 10.1126/scitranslmed.3004676. Erratum in: Sci Transl Med. 2016 Apr 20;8(335):335er4.

12.

Neuropeptide Y and its role in CNS disease and repair.

Decressac M, Barker RA.

Exp Neurol. 2012 Dec;238(2):265-72. doi: 10.1016/j.expneurol.2012.09.004. Epub 2012 Sep 27. Review.

PMID:
23022456
13.

Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.

Decressac M, Mattsson B, Björklund A.

Exp Neurol. 2012 May;235(1):306-15. doi: 10.1016/j.expneurol.2012.02.012. Epub 2012 Feb 25.

PMID:
22394547
14.

Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons.

Lundblad M, Decressac M, Mattsson B, Björklund A.

Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3213-9. doi: 10.1073/pnas.1200575109. Epub 2012 Feb 6.

15.

Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.

Decressac M, Mattsson B, Lundblad M, Weikop P, Björklund A.

Neurobiol Dis. 2012 Mar;45(3):939-53. doi: 10.1016/j.nbd.2011.12.013. Epub 2011 Dec 11.

PMID:
22182688
16.

Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.

Decressac M, Pain S, Chabeauti PY, Frangeul L, Thiriet N, Herzog H, Vergote J, Chalon S, Jaber M, Gaillard A.

Neurobiol Aging. 2012 Sep;33(9):2125-37. doi: 10.1016/j.neurobiolaging.2011.06.018. Epub 2011 Aug 3.

PMID:
21816512
17.

GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.

Decressac M, Ulusoy A, Mattsson B, Georgievska B, Romero-Ramos M, Kirik D, Björklund A.

Brain. 2011 Aug;134(Pt 8):2302-11. doi: 10.1093/brain/awr149. Epub 2011 Jun 28.

PMID:
21712347
18.

Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson's disease.

Ulusoy A, Decressac M, Kirik D, Björklund A.

Prog Brain Res. 2010;184:89-111. doi: 10.1016/S0079-6123(10)84005-1. Review.

PMID:
20887871
19.

Neuropeptide Y modifies the disease course in the R6/2 transgenic model of Huntington's disease.

Decressac M, Wright B, Tyers P, Gaillard A, Barker RA.

Exp Neurol. 2010 Nov;226(1):24-32. doi: 10.1016/j.expneurol.2010.07.022. Epub 2010 Jul 29.

PMID:
20673761
20.

In-vivo deep brain recordings of intranigral grafted cells in a mouse model of Parkinson's disease.

Besnard S, Decressac M, Denise P.

Neuroreport. 2010 May 12;21(7):485-9.

PMID:
20405544
21.

Environmental enrichment does not reduce the rewarding and neurotoxic effects of methamphetamine.

Thiriet N, Gennequin B, Lardeux V, Chauvet C, Decressac M, Janet T, Jaber M, Solinas M.

Neurotox Res. 2011 Jan;19(1):172-82. doi: 10.1007/s12640-010-9158-2. Epub 2010 Feb 9.

PMID:
20143198
22.

Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis.

Decressac M, Wright B, David B, Tyers P, Jaber M, Barker RA, Gaillard A.

Hippocampus. 2011 Mar;21(3):233-8. doi: 10.1002/hipo.20765.

PMID:
20095007
23.

Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.

Gaillard A, Decressac M, Frappé I, Fernagut PO, Prestoz L, Besnard S, Jaber M.

Neurobiol Dis. 2009 Sep;35(3):477-88. doi: 10.1016/j.nbd.2009.07.003. Epub 2009 Jul 17.

PMID:
19616502
24.

Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice.

Decressac M, Prestoz L, Veran J, Cantereau A, Jaber M, Gaillard A.

Neurobiol Dis. 2009 Jun;34(3):441-9. doi: 10.1016/j.nbd.2009.02.017. Epub 2009 Mar 10.

PMID:
19285132

Supplemental Content

Loading ...
Support Center